Inventor
ZHOU JIACHENG
US89 patents
⚠️ This page may combine multiple inventors who share the name “ZHOU JIACHENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
33 patentsUS9290506B2Mar 22, 2016
Processes for preparing JAK inhibitors and related intermediate compounds
INCYTE CORP60 citations98
US11174257B2Nov 16, 2021
Salts of an FGFR inhibitor
INCYTE CORP21 citations94
US10626114B2Apr 21, 2020
Crystalline solid forms of a BET inhibitor
INCYTE CORP15 citations94
US10329305B2Jun 25, 2019
Amorphous solid form of a BET protein inhibitor
INCYTE CORP16 citations94
US10189832B2Jan 29, 2019
Crystalline solid forms of a BET inhibitor
INCYTE CORP23 citations94
US10336759B2Jul 2, 2019
Salts and processes of preparing a PI3K inhibitor
INCYTE CORP18 citations93
US10329255B2Jun 25, 2019
Salts of an LSD1 inhibitor
INCYTE CORP15 citations93
US9862705B2Jan 9, 2018
Salts of a pim kinase inhibitor
INCYTE CORP13 citations92
US9802957B2Oct 31, 2017
Processes of preparing a JAK1 inhibitor and new forms thereto
INCYTE CORP28 citations92
US9321755B2Apr 26, 2016
Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
INCYTE CORP15 citations92
US12030882B2Jul 9, 2024
Crystalline solid forms of a bet inhibitor
INCYTE CORP3 citations86
US11760756B2Sep 19, 2023
Crystalline form of a PD-1/PD-L1 inhibitor
INCYTE CORP9 citations86
US11753406B2Sep 12, 2023
Salts of a PD-1/PD-L1 inhibitor
INCYTE CORP9 citations86
US11377446B2Jul 5, 2022
Crystalline solid forms of a BET inhibitor
INCYTE CORP8 citations86
US11866451B2Jan 9, 2024
Salts and crystalline forms of a PD-1/PD-L1 inhibitor
INCYTE CORP7 citations85
US11780836B2Oct 10, 2023
Process of preparing a PD-1/PD-L1 inhibitor
INCYTE CORP8 citations85
US11472801B2Oct 18, 2022
Crystalline forms of a FGFR inhibitor and processes for preparing the same
INCYTE CORP9 citations84
US11104682B2Aug 31, 2021
Salts of TAM inhibitors
INCYTE CORP7 citations84
US11091480B2Aug 17, 2021
Crystalline solid forms of a BET inhibitor
INCYTE CORP8 citations84
US10858372B2Dec 8, 2020
Amorphous solid form of a BET protein inhibitor
INCYTE CORP10 citations84
US10799509B2Oct 13, 2020
Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
INCYTE CORP3 citations84
US10633387B2Apr 28, 2020
Salts of TAM inhibitors
INCYTE CORP10 citations84
US10450325B2Oct 22, 2019
Processes of preparing a JAK1 inhibitor and new forms thereto
INCYTE CORP11 citations84
US10245265B2Apr 2, 2019
Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
INCYTE CORP6 citations84
US9718834B2Aug 1, 2017
Processes and intermediates for making a JAK inhibitor
INCYTE CORP10 citations84
US11866434B2Jan 9, 2024
Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
INCYTE CORP7 citations83
US11084822B2Aug 10, 2021
Salts and processes of preparing a PI3K inhibitor
INCYTE CORP7 citations83
US10968200B2Apr 6, 2021
Salts of an LSD1 inhibitor and processes for preparing the same
INCYTE CORP5 citations83
US10899736B2Jan 26, 2021
Processes and intermediates for making a JAK inhibitor
INCYTE CORP7 citations83
US10723700B2Jul 28, 2020
Salts of an LSD1 inhibitor
INCYTE CORP7 citations83
US12187730B2Jan 7, 2025
Salts of TAM inhibitors
INCYTE CORP1 citations75
US12024517B2Jul 2, 2024
Salts of an FGFR inhibitor
INCYTE CORP3 citations75
US12084443B2Sep 10, 2024
Process of preparing a PD-1/PD-L1 inhibitor
INCYTE CORP5 citations74
ZHOU JIACHENG
5 patentsUS8883806B2Nov 11, 2014
Processes for preparing JAK inhibitors and related intermediate compounds
ZHOU JIACHENG76 citations99
US9000161B2Apr 7, 2015
Processes for preparing JAK inhibitors and related intermediate compounds
ZHOU JIACHENG67 citations98
US8410265B2Apr 2, 2013
Processes for preparing JAK inhibitors and related intermediate compounds
ZHOU JIACHENG136 citations98
US9487521B2Nov 8, 2016
Processes and intermediates for making a JAK inhibitor
ZHOU JIACHENG74 citations97
US8993582B2Mar 31, 2015
Processes for preparing JAK inhibitors and related intermediate compounds
ZHOU JIACHENG60 citations97
RIB X PHARMACEUTICALS INC
3 patentsUS6969726B2Nov 29, 2005
Biaryl heterocyclic compounds and methods of making and using the same
RIB X PHARMACEUTICALS INC44 citations95
US7148219B2Dec 12, 2006
Biaryl heterocyclic compounds and methods of making and using the same
RIB X PHARMACEUTICALS INC28 citations92
US7129259B2Oct 31, 2006
Halogenated biaryl heterocyclic compounds and methods of making and using the same
RIB X PHARMACEUTICALS INC31 citations92
INCYTE HOLDINGS CORP
3 patentsUS10975085B2Apr 13, 2021
Process for preparing a composition comprising an enantiomeric excess of greater than or equal to 90% of the (R)-enantiomer of a compound of formula III
INCYTE HOLDINGS CORP5 citations84
US10364248B2Jul 30, 2019
Processes for preparing 4-chloro-7H-pyrrolo[2,3-d]pyrimidine
INCYTE HOLDINGS CORP5 citations84
US9908888B2Mar 6, 2018
Processes for preparing pyrazolyl-substituted pyrrolo[2,3-d]pyrimidines
INCYTE HOLDINGS CORP6 citations84
WENG LINGKAI
2 patentsUS8420645B2Apr 16, 2013
Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
WENG LINGKAI49 citations96
US8901123B2Dec 2, 2014
Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
WENG LINGKAI14 citations91
BRISTOL MYERS SQUIBB CO
2 patentsBRISTOL MYERS SQUIBB PHARMA CO
1 patentCOMBS ANDREW P
1 patentShowing the top 50 of 89 patents by PatentIndex Score.